Vaxfab Enterprises Limited (VEL.BO)
INR 10.48
(0.29%)
INR 10.48
(0.29%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -72.98 Million | 18.03 Million | -1.55 Million | -12.13 Million | 3.81 Million | 9.94 Million |
| Net Income | -35.32 Million | 3.34 Million | 24 Thousand | -122.6 Thousand | -121.55 Thousand | 357.31 Thousand |
| Depreciation & Amortization | 492 Thousand | 89 Thousand | 89 Thousand | 88.8 Thousand | 88.8 Thousand | 88.8 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -30.6 Million | 13.68 Million | -1.66 Million | -12.1 Million | 3.84 Million | 9.5 Million |
| Other non-cash items | -5.6 Million | -18.22 Million | -5.99 Million | 11.68 Million | -337.74 Thousand | 1.79 Million |
| Investing Cash Flow | 37.07 Million | -119.9 Million | - | 7.7 Million | -7.7 Million | 313.17 Thousand |
| Investments in PPE | -17 Thousand | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -119.9 Million | - | - | -7.7 Million | - |
| Sales/Maturities of investments | 37.09 Million | - | - | 7.7 Million | - | 313.17 Thousand |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -2.51 Million | 143.59 Million | 1.77 Million | 4.43 Million | 3.6 Million | -10.21 Million |
| Debt repayment | -2.51 Million | -13.99 Million | -450 Thousand | -698 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 129.6 Million | - | - | - | - |
| Other Financing Activities | - | 10.83 Million | 2.22 Million | 3.73 Million | 3.6 Million | -10.21 Million |
| Accounts receivables | 963 Thousand | -32.08 Million | 6.33 Million | -11.73 Million | -1.02 Million | -62.31 Thousand |
| Accounts payables | -43.57 Million | 96.71 Million | -161 Thousand | -2.75 Million | 1.58 Million | -1.97 Million |
| Inventory | 41.65 Million | -45.32 Million | - | 2.98 Million | -40 Thousand | 413.95 Thousand |
| Other working capital | -29.64 Million | -5.62 Million | -7.83 Million | -597.39 Thousand | 3.32 Million | 11.12 Million |
| Cash at beginning of period | 41.94 Million | 236 Thousand | 12.8 Thousand | 15.05 Thousand | 298.21 Thousand | 256.87 Thousand |
| Cash at end of period | 3.51 Million | 41.94 Million | 236 Thousand | 12.8 Thousand | 15.05 Thousand | 298.21 Thousand |
| Capital Expenditure | -17 Thousand | - | - | - | - | - |
| Effect of forex changes on cash | - | -1000.00 | - | - | - | - |
| Net cash flow / Change in cash | -38.42 Million | 41.71 Million | 223.19 Thousand | -2255.00 | -283.15 Thousand | 41.34 Thousand |
| Free Cash Flow | -73 Million | 18.03 Million | -1.55 Million | -12.13 Million | 3.81 Million | 9.94 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -35.32 Million | -44.74 Million | 1.01 Million | 2.62 Million | 2.78 Million | 3.34 Million |
| Depreciation & Amortization | 492 Thousand | 123 Thousand | 124 Thousand | 122 Thousand | 22 Thousand | 89 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -30.6 Million | - | - | - | - | 13.68 Million |
| Other non-cash items | -5.6 Million | -123 Thousand | -124 Thousand | -122 Thousand | -22 Thousand | -18.22 Million |
| Investing Cash Flow | 37.07 Million | - | - | - | - | -119.9 Million |
| Investments in PPE | -17 Thousand | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -119.9 Million |
| Sales/Maturities of investments | 37.09 Million | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -2.51 Million | - | - | - | - | 143.59 Million |
| Debt repayment | -2.51 Million | - | - | - | - | -13.99 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 129.6 Million |
| Other Financing Activities | - | - | - | - | - | 10.83 Million |
| Accounts receivables | 963 Thousand | - | - | - | - | -32.08 Million |
| Accounts payables | -43.57 Million | - | - | - | - | 96.71 Million |
| Inventory | 41.65 Million | - | - | - | - | -45.32 Million |
| Other working capital | -29.64 Million | - | - | - | - | -5.62 Million |
| Cash at beginning of period | 41.94 Million | 2.48 Million | 1.47 Million | 41.94 Million | 39.16 Million | 236 Thousand |
| Cash at end of period | 3.51 Million | -44.74 Million | 2.48 Million | 2.62 Million | 41.94 Million | 41.94 Million |
| Capital Expenditure | -17 Thousand | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | -1000.00 |
| Net cash flow / Change in cash | -38.42 Million | -47.22 Million | 1.01 Million | -39.32 Million | 2.78 Million | 41.71 Million |
| Free Cash Flow | -73 Million | -44.74 Million | 1.01 Million | 2.62 Million | 2.78 Million | 18.03 Million |
200570
SHIM
NR21
BSSP
VERA
2303